Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Health and Quality of Life Outcomes|July 27, 2018
Quality of life in adults with lymphedema cholestasis syndrome 1Kristin Iversen, Lill Monica Drivdal, Kristin J Billaud Feragen, et al.
Melanoma Research|December 4, 2003
Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigensChristina M Lohmann, Wen Jen Hwu, Kristin Iversen, et al.
Orphanet Journal of Rare Diseases|September 29, 2015
Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based studyMarleen R van Walsem, Emilie I Howe, Kristin Iversen, et al.
Head & Neck|October 30, 2004
Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neckManju L Prasad, Achim A Jungbluth, Snehal G Patel, et al.
Human Pathology|April 17, 2002
MAGE antigen expression in monophasic and biphasic synovial sarcomaCristina R Antonescu, Klaus J Busam, Kristin Iversen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2004
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarrayDhananjay A Chitale, Achim A Jungbluth, David S Marshall, et al.
International Journal of Cancer|July 13, 2002
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissuesAchim A Jungbluth, Yao-Tseng Chen, Klaus J Busam, et al.
Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.
Cancer Immunity|July 24, 2003
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of diseaseMadhav V Dhodapkar, Keren Osman, Julie Teruya-Feldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2003
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptorAchim A Jungbluth, Elisabeth Stockert, H J Su Huang, et al.
Pageof 1